Cargando…

Generation of MERS-CoV Pseudotyped Viral Particles for the Evaluation of Neutralizing Antibodies in Mammalian Sera

Pseudotyped viral particle production has been used extensively and broadly for many viruses to evaluate levels of neutralizing antibodies, viral entry inhibitors and vaccine immunogenicity. This assay is extremely safe and useful alternative to live virus-based assay without the need for high conta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almasaud, Abdulrahman, Alharbi, Naif Khalaf, Hashem, Anwar M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123069/ https://www.ncbi.nlm.nih.gov/pubmed/31883092 http://dx.doi.org/10.1007/978-1-0716-0211-9_10

Ejemplares similares

Evaluation of MERS-CoV Neutralizing Antibodies in Sera Using Live Virus Microneutralization Assay
por: Algaissi, Abdullah, et al.
Publicado: (2019)

Reliability of Pseudotyped Influenza Viral Particles in Neutralizing Antibody Detection
por: Yang, Jinghui, et al.
Publicado: (2014)

Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience
por: Algaissi, Abdullah A., et al.
Publicado: (2020)

The Use of Hyperimmune Chicken Reference Sera Is Not Appropriate for the Validation of Influenza Pseudotype Neutralization Assays
por: Ferrara, Francesca, et al.
Publicado: (2017)

Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles
por: Moeschler, Sarah, et al.
Publicado: (2016)

An optimised method for the production of MERS-CoV spike expressing viral pseudotypes
por: Grehan, K., et al.
Publicado: (2015)

Vaccination strategies for mitigation of MERS-CoV outbreaks
por: Bosaeed, Mohammad, et al.
Publicado: (2023)

Chimeric influenza haemagglutinins: Generation and use in pseudotype neutralization assays
por: Ferrara, Francesca, et al.
Publicado: (2016)

Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
por: Temperton, Nigel J., et al.
Publicado: (2005)

Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection
por: Liu, Zezhong, et al.
Publicado: (2020)

Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016
por: Degnah, Afnan A., et al.
Publicado: (2020)

Non-SARS Non-MERS Human Coronaviruses: Clinical Characteristics and Outcome
por: Saib, Israa, et al.
Publicado: (2021)

Detection of viral antibodies in camel sera using magnetic particle spectroscopy
por: Friedrich, Bernhard, et al.
Publicado: (2023)

Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin
por: Pleckaityte, Milda, et al.
Publicado: (2011)

Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles
por: Chen, Catherine Z., et al.
Publicado: (2020)

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
por: Condor Capcha, Jose Manuel, et al.
Publicado: (2021)

Pseudotyping exosomes for enhanced protein delivery in mammalian cells
por: Meyer, Conary, et al.
Publicado: (2017)

Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison
por: Wright, Edward, et al.
Publicado: (2008)

Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses
por: Sampson, Alexander Thomas, et al.
Publicado: (2021)

Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells
por: Bakillah, Ahmed, et al.
Publicado: (2022)

High Rate of Circulating MERS-CoV in Dromedary Camels at Slaughterhouses in Riyadh, 2019
por: Aljasim, Taibah A., et al.
Publicado: (2020)

Neutralizing Antibody to Vesicular Stomatitis Virus (HTLV‐I) Pseudotype in Infants Born to Seropositive Mothers
por: Iwahara, Yoshihito, et al.
Publicado: (1993)

A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
por: Temperton, Nigel J., et al.
Publicado: (2007)

Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype
por: Mercier-Delarue, Séverine, et al.
Publicado: (2017)

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
por: Schmidt, Fabian, et al.
Publicado: (2020)

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
por: Schmidt, Fabian, et al.
Publicado: (2020)

Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody
por: Kim, Sang Il, et al.
Publicado: (2019)

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
por: Crawford, Katharine H. D., et al.
Publicado: (2020)

Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis
por: Carnell, George William, et al.
Publicado: (2015)

Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis
por: Ferrara, Francesca, et al.
Publicado: (2018)

Qualitative and Quantitative Determination of MERS-CoV S1-Specific Antibodies Using ELISA
por: Al-amri, Sawsan S., et al.
Publicado: (2019)

HUMAN ALLERGY TO MAMMALIAN SERA
por: Simon, Frank A.
Publicado: (1942)

Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen
por: Pleckaityte, Milda, et al.
Publicado: (2015)

Transcriptomic Profiling of Dromedary Camels Immunised with a MERS Vaccine Candidate
por: Hala, Sharif, et al.
Publicado: (2021)

A Human DPP4-Knockin Mouse’s Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV
por: Fan, Changfa, et al.
Publicado: (2018)

Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27
por: Yu, Xiaojuan, et al.
Publicado: (2015)

Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes
por: Tomás, Hélio A., et al.
Publicado: (2019)

The role of pseudotype neutralization assays in understanding SARS CoV-2
por: Cantoni, Diego, et al.
Publicado: (2021)

Induction of neutralizing antibodies by human papillomavirus vaccine generated in mammalian cells
por: Wu, Xilin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2069lqn1ofqhdiuuf3ccdm9usi